Immunomedics makes $10 million placement

Article

Monoclonal antibody imaging agent developer Immunomedics of MorrisPlains, NJ, announced last week that it has sold $10 million inconvertible preferred stock to international investors. The investorscan convert the stock into shares of common stock over

Monoclonal antibody imaging agent developer Immunomedics of Morris

Plains, NJ, announced last week that it has sold $10 million in

convertible preferred stock to international investors. The investors

can convert the stock into shares of common stock over the next

two years.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
AI Denoising Bolsters Ultra-Low-Dose CT Detection of Pneumonia Findings in Immunocompromised Adults

AI Denoising Bolsters Ultra-Low-Dose CT Detection of Pneumonia Findings in Immunocompromised Adults

Jeff Hall
March 14th 2025
Article

For immunocompromised individuals, denoised ultra-low-dose CT offers similar detail as normal-dose CT scans for pneumonia detection, according to a recent study.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Vave Health Unveils Handheld, Whole-Body Ultrasound Device

Vave Health Unveils Handheld, Whole-Body Ultrasound Device

Jeff Hall
March 13th 2025
Article

Emphasizing intuitive workflow and portability, the Universal Wireless Probe reportedly offers a cost-effective combination of phased and linear ultrasound imaging.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

Jeff Hall
August 23rd 2023
Podcast

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

Canon Medical Launches Hybrid Radiography/Fluoroscopy System

Canon Medical Launches Hybrid Radiography/Fluoroscopy System

Jeff Hall
March 12th 2025
Article

Enabling radiographic and low-dose fluoroscopy exams in the same room, the Adora DRFi system emphasizes a variety of advances for flexibility with patient positioning.

Study: Generative AI Model Reduces CXR Reading Time by 42 Percent

Study: Generative AI Model Reduces CXR Reading Time by 42 Percent

Jeff Hall
March 12th 2025
Article

In addition to a significant reduction of X-ray reading time, researchers found the use of multimodal generative AI assessment led to enhanced detection of pleural lesions and widened mediastinal silhouettes.

© 2025 MJH Life Sciences

All rights reserved.